2,921
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Anti-EGF antibodies as surrogate biomarkers of clinical efficacy in stage IIIB/IV non-small-cell lung cancer patients treated with an optimized CIMAvax-EGF vaccination schedule

, , , , , , , , , , & show all
Article: 1762465 | Received 24 Jan 2020, Accepted 29 Mar 2020, Published online: 25 May 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.